Fungal Keratitis Treatment Market Report 2024: Global Trends, Forecast and Competitive Analysis to 2030 Featuring Merck & Co, Bausch Health, Gilead Biosciences, Pfizer, and Glenmark Pharmaceuticals
April 19, 2024 09:24 ET
|
Research and Markets
Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The "Fungal Keratitis Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's...
Fungal Keratitis Treatment Market Size Projections Exhibit a CAGR of 5.1%, Likely to Attain a Value of USD 1.48 Billion by 2033
April 17, 2024 22:00 ET
|
The Brainy Insights
Newark, April 17, 2024 (GLOBE NEWSWIRE) -- The Brainy Insights estimates that the USD 0.90 billion fungal keratitis treatment market will reach USD 1.48 billion by 2033. A fungal infection of the...
Fungal Keratitis Treatment Market Size is projected to reach USD 1.32 Billion by 2030, growing at a CAGR of 6%: Straits Research
July 14, 2022 13:00 ET
|
Straits Research
New York, United States, July 14, 2022 (GLOBE NEWSWIRE) -- The fungal keratitis treatment market is driven by the increasing prevalence of such diseases worldwide, rising awareness of the potential...